|
Re: Monday
|
14
|
Resverlogix Corp.
|
Oct 01, 2020 07:33PM
|
|
Re: More exposure
|
6
|
Resverlogix Corp.
|
May 20, 2021 11:51AM
|
|
Re: New Publication
|
8
|
Resverlogix Corp.
|
Feb 28, 2023 02:15PM
|
|
Re: New video
|
8
|
Resverlogix Corp.
|
Aug 03, 2021 11:07AM
|
|
Re: Nice run for Hepa over the holidays
|
3
|
Resverlogix Corp.
|
Jan 06, 2020 11:39PM
|
|
Re: No change in Ottawa.
|
|
Resverlogix Corp.
|
Sep 21, 2021 04:50PM
|
|
Re: Optimistic
|
9
|
Resverlogix Corp.
|
Oct 19, 2021 10:06AM
|
|
Re: Presentation May 12th
|
7
|
Resverlogix Corp.
|
May 09, 2021 11:50AM
|
|
Re: Presentation May 12th
|
5
|
Resverlogix Corp.
|
May 06, 2021 08:27PM
|
|
Re: Primary outcome HR= .82 (18% RRR) P=0.11
|
1
|
Resverlogix Corp.
|
Nov 16, 2019 12:01PM
|
|
Re: Question for posters
|
5
|
Resverlogix Corp.
|
Dec 10, 2021 11:36AM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
4
|
Resverlogix Corp.
|
Dec 05, 2019 08:10PM
|
|
Re: Resverlogix Announces $13 Million Private Placement
|
5
|
Resverlogix Corp.
|
Oct 06, 2020 03:51PM
|
|
Re: Resverlogix Announces $13 Million Private Placement
|
9
|
Resverlogix Corp.
|
Oct 07, 2020 12:40PM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
8
|
Resverlogix Corp.
|
Jan 18, 2022 08:24AM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
2
|
Resverlogix Corp.
|
Oct 14, 2020 11:07AM
|
|
Re: Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
1
|
Resverlogix Corp.
|
Mar 31, 2020 10:06AM
|
|
Re: Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews
|
3
|
Resverlogix Corp.
|
Sep 15, 2020 09:22AM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
11
|
Resverlogix Corp.
|
Jun 22, 2022 12:16PM
|
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
8
|
Resverlogix Corp.
|
Oct 04, 2020 01:18PM
|
